These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8974569)

  • 1. [A critical evaluation of the therapeutic value of calcium antagonists].
    Metelitsa VI
    Eksp Klin Farmakol; 1996; 59(2):56-61. PubMed ID: 8974569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current conception of calcium antagonists use in cardiology. A. L. Miasnikov Research Institute of Cardiology].
    Scientific Society
    Klin Med (Mosk); 1996; 74(4):70-1. PubMed ID: 8999167
    [No Abstract]   [Full Text] [Related]  

  • 3. The calcium channel blocker controversy--caveats for the practitioner and pharmacist.
    Bhagat K
    Cent Afr J Med; 2000 Jun; 46(6):169-70. PubMed ID: 11235061
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nifedipine in ischemic heart disease: a ban on its use or a differential approach to therapy?].
    Martsevich SIu
    Ter Arkh; 1996; 68(9):31-5. PubMed ID: 9005608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release calcium channel antagonists in cardiovascular disease: pharmacology and current therapeutic use.
    Silvestry FE; St John Sutton MG
    Eur Heart J; 1998 Aug; 19 Suppl I():I8-14. PubMed ID: 9743438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Views on the use of calcium channel blockers in the treatment of heart ischemia and hypertension].
    Halawa B
    Pol Merkur Lekarski; 1998 Sep; 5(27):107-10. PubMed ID: 10101470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are there any withdrawal complications with nitro derivatives and calcium antagonists?].
    Guerot C
    Therapie; 1985; 40(1):35-9. PubMed ID: 4002182
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current controversies concerning the use of calcium antagonists].
    Rossi G
    Recenti Prog Med; 1996 Mar; 87(3):114-7. PubMed ID: 8650431
    [No Abstract]   [Full Text] [Related]  

  • 9. [Calcium channel antagonists and non-cardiac surgery in ischemic cardiopathy].
    Gómez-Arnau J
    Rev Esp Anestesiol Reanim; 1998 Dec; 45(10):407-8. PubMed ID: 9927830
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium channel blockers in myocardial and cerebral ischemia: a clinician's review from bench to bedside.
    Borger MA; Weisel RD
    Can J Cardiol; 1999 Mar; 15(3):333-40. PubMed ID: 10202197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists and ischemic heart disease].
    Matsuoka H; Imaizumi T
    Clin Calcium; 2005 Oct; 15(10):1623-30. PubMed ID: 16199907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The current concept of the use of calcium antagonists in cardiology. Resolution of the Academic Council of the A. L. Miasnikov Research Institute of Cardiology of the KNTs of the Russian Academy of Medical Sciences].
    Ter Arkh; 1996; 68(9):18-9. PubMed ID: 9005604
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficiency and safety of a long-lasting form of diltiazem in the treatment of hypertensive patients with ischemic heart disease].
    Svetyĭ LI; Pavlova LI; Mazerkina IA
    Klin Med (Mosk); 2002; 80(8):58-61. PubMed ID: 12360623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug interactions with calcium antagonists].
    Stricker M
    Schweiz Rundsch Med Prax; 1985 May; 74(19):514-6. PubMed ID: 4012135
    [No Abstract]   [Full Text] [Related]  

  • 16. [Heart rate control: f-channel blockers].
    Kryzhanovskiĭ SA; Vititnova MB
    Fiziol Cheloveka; 2009; 35(2):112-23. PubMed ID: 19402561
    [No Abstract]   [Full Text] [Related]  

  • 17. [There is no reason to avoid calcium antagonists in hypertension].
    Hansson L; Hansson BG; Hedner T
    Lakartidningen; 1996 Aug; 93(35):2918. PubMed ID: 8815344
    [No Abstract]   [Full Text] [Related]  

  • 18. Nisoldipine coat-core and heart rate response during treatment of hypertension.
    Zannad F
    Int J Clin Pract; 1999; 53(1):65-71. PubMed ID: 10344070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium channel blockers in the treatment of hypertension and ischemic coronary disease. Conflicts in their evaluation].
    Mayer O
    Cas Lek Cesk; 1998 Apr; 137(7):216-9. PubMed ID: 9650344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blockers in the management of hypertension.
    Fitzgerald D
    Ir Med J; 1996; 89(1):8. PubMed ID: 8984083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.